PDA Points To Consider: Technical Product Lifecycle Management: Communication and Knowledge Exchange between Marketing Authorization Holders and Health Authorities.
Authors: Members of the PDA Task Force Post Approval Changes for Innovation in Availability of Medicines (PAC iAM); Ramnarine E, Busse U, Colao M, Edwards J, Jornitz M, Munk M, Seymour M, Simianu M, Skeens L, Vinther A.
Authors: Members of the PDA Task Force Post Approval Changes for Innovation in Availability of Medicines (PAC iAM), et al. Among authors: jornitz m.
PDA J Pharm Sci Technol. 2017 Mar-Apr;71(2):163-169. doi: 10.5731/pdajpst.2016.007492. Epub 2017 Jan 15.
PDA J Pharm Sci Technol. 2017.
PMID: 28089963
Review.
No abstract available.